Coeptis Therapeutics Holdings, Inc. agreed to issue 400,000 shares of common stock and 100,000 shares of common stock of the Company to Biofin Ventures, LLC and AG Bio Life Capital I LP respectively on September 29, 2023.The company will receive gross proceeds of $400,000 and $100,000 from Biofin Ventures, LLC and AG Bio Life Capital I LP respectively.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.285 USD | +1.42% |
|
+0.42% | -63.64% |
Jun. 17 | Ladenburg Downgrades Coeptis Therapeutics to Neutral From Buy | MT |
Jun. 14 | Coeptis Therapeutics Holdings, Inc. announced that it has received $4.3 million in funding | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-63.64% | 10.58M | |
+57.48% | 827B | |
-7.18% | 350B | |
+15.37% | 319B | |
+7.45% | 294B | |
+14.17% | 240B | |
+15.28% | 221B | |
+0.94% | 219B | |
+8.14% | 167B | |
-2.99% | 158B |
- Stock Market
- Equities
- COEP Stock
- News Coeptis Therapeutics Holdings, Inc.
- Coeptis Therapeutics Holdings, Inc. announced that it expects to receive $0.5 million in funding